Allogene Therapeutics Inc

Available to platforms
R StocksTrader
Allogene Therapeutics, Inc. is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Allogene Therapeutics treats patients in Carlifornia, in the US.

Allogene Therapeutics Inc - ALLO stocks live chart

Analyze price movements of Allogene Therapeutics Inc online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous ALLO quotes – including the latest bid at 1.1 USD and ask at 1.13 USD – and get all the necessary information for adding Allogene Therapeutics Inc to your investment portfolio.

With R StocksTrader, you can invest in Allogene Therapeutics Inc and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Allogene Therapeutics Inc, and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of ALLO does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Allogene Therapeutics Inc (ALLO).

You can trade Allogene Therapeutics Inc (ALLO) on the R StocksTrader platform.

You can trade online Allogene Therapeutics Inc (ALLO) on Prime, ECN, Pro, or R StocksTrader accounts.